AJR Customized AJR reprints in quantities as low as 100!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cioni, D.
Right arrow Articles by Bartolozzi, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cioni, D.
Right arrow Articles by Bartolozzi, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2001; 177:783-788
© American Roentgen Ray Society


Radiofrequency Thermal Ablation of Hepatocellular Carcinoma

Using Contrast-Enhanced Harmonic Power Doppler Sonography to Assess Treatment Outcome

Dania Cioni1, Riccardo Lencioni1, Sandro Rossi2, Francesco Garbagnati3, Francescamaria Donati1, Laura Crocetti1 and Carlo Bartolozzi1

1 Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants, and Advanced Technologies in Medicine, University of Pisa, Via Roma 67, I-56125 Pisa, Italy.
2 Unit of Interventional Ultrasound, Policlinico S. Matteo IRCCS, Via Golgi 6, I-90133 Pavia, Italy.
3 Department of Radiology, National Cancer Institute, Via Venezian 1, I-20133 Milan, Italy.

OBJECTIVE. We evaluated the accuracy of contrast-enhanced harmonic power Doppler sonography in assessing the outcome of radiofrequency thermal ablation of hepatocellular carcinoma.

SUBJECTS AND METHODS. Fifty patients with 65 hepatocellular carcinoma nodules (1-5 cm in diameter; mean diameter, 2.5 cm) were studied using unenhanced and contrast-enhanced harmonic power Doppler sonography before and after IV administration of a microbubble contrast agent. The examinations were repeated after treatment of the tumors with radiofrequency ablation. Findings of the Doppler studies were compared with those of dual-phase helical CT, which were used as points of reference for assessing treatment outcome.

RESULTS. Before radiofrequency treatment, intratumoral blood flow was revealed by unenhanced power Doppler sonography in 48 (74%) of 65 hepatocellular carcinoma nodules. After injection of the contrast agent, intratumoral enhancement was observed in 61 (94%) of 65 hepatocellular carcinomas (p < 0.01). After radiofrequency treatment, all 51 (84%) of the 61 hepatocellular carcinomas found to be necrotic on helical CT scans failed to show enhancement on power Doppler sonograms. In nine of the 10 lesions that showed a residual viable tumor on helical CT scans, persistent intratumoral enhancement—matching the enhancing areas on helical CT images—was revealed by power Doppler sonography. These nine hepatocellular carcinomas were subjected to repeated radiofrequency thermal ablation with the guidance of contrast-enhanced power Doppler sonography. Complete necrosis was seen after the second treatment session in six of the nine lesions.

CONCLUSION. Contrast-enhanced harmonic power Doppler sonography is an accurate technique for assessing the outcome of radiofrequency thermal ablation of hepatocellular carcinoma and may be useful in guiding additional treatment in patients with incomplete response to initial efforts.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
Y. Minami, H. Chung, M. Kudo, S. Kitai, S. Takahashi, T. Inoue, K. Ueshima, and H. Shiozaki
Radiofrequency Ablation of Hepatocellular Carcinoma: Value of Virtual CT Sonography with Magnetic Navigation
Am. J. Roentgenol., June 1, 2008; 190(6): W335 - W341.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
K. Numata, M. Morimoto, T. Ogura, K. Sugimori, S. Takebayashi, M. Okada, and K. Tanaka
Ablation Therapy Guided by Contrast-Enhanced Sonography with Sonazoid for Hepatocellular Carcinoma Lesions Not Detected by Conventional Sonography
J. Ultrasound Med., March 1, 2008; 27(3): 395 - 406.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
S.-Y. Chiou, J.-B. Liu, and L. Needleman
Current Status of Sonographically Guided Radiofrequency Ablation Techniques
J. Ultrasound Med., April 1, 2007; 26(4): 487 - 499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
Y. Minami, M. Kudo, H. Chung, T. Kawasaki, Y. Yagyu, T. Shimono, and H. Shiozaki
Contrast Harmonic Sonography-Guided Radiofrequency Ablation Therapy Versus B-Mode Sonography in Hepatocellular Carcinoma: Prospective Randomized Controlled Trial
Am. J. Roentgenol., February 1, 2007; 188(2): 489 - 494.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
W. Wu, M.-H. Chen, S.-S. Yin, K. Yan, Z.-H. Fan, W. Yang, Y. Dai, L. Huo, and J.-Y. Li
The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy.
Am. J. Roentgenol., September 1, 2006; 187(3): 752 - 761.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. Hirooka, H. Iuchi, T. Kumagi, S. Shigematsu, A. Hiraoka, T. Uehara, K. Kurose, N. Horiike, and M. Onji
Virtual Sonographic Radiofrequency Ablation of Hepatocellular Carcinoma Visualized on CT but Not on Conventional Sonography.
Am. J. Roentgenol., May 1, 2006; 186(5 Suppl): S255 - S260.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. J. Dill-Macky, M. Asch, P. Burns, and S. Wilson
Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
Am. J. Roentgenol., May 1, 2006; 186(5 Suppl): S287 - S295.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
M. Morimoto, A. Nozawa, K. Numata, K. Shirato, K. Sugimori, A. Kokawa, N. Tomita, T. Saitou, Y. Nakatani, T. Imada, et al.
Evaluation Using Contrast-Enhanced Harmonic Gray Scale Sonography After Radio Frequency Ablation of Small Hepatocellular Carcinoma: Sonographic-Histopathologic Correlation
J. Ultrasound Med., March 1, 2005; 24(3): 273 - 283.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
D. S. K. Lu, N. C. Yu, S. S. Raman, P. Limanond, C. Lassman, K. Murray, M. J. Tong, R. G. Amado, and R. W. Busuttil
Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Success as Defined by Histologic Examination of the Explanted Liver
Radiology, March 1, 2005; 234(3): 954 - 960.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
A R Gillams
Liver ablation therapy
Br. J. Radiol., September 1, 2004; 77(921): 713 - 723.
[Full Text] [PDF]


Home page
J Ultrasound MedHome page
S. Sartori, I. Nielsen, L. Trevisani, P. Tombesi, P. Ceccotti, and V. Abbasciano
Contrast-Enhanced Sonography as Guidance for Transthoracic Biopsy of a Peripheral Lung Lesion With Large Necrotic Areas
J. Ultrasound Med., January 1, 2004; 23(1): 133 - 136.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Numata, T. Isozaki, Y. Ozawa, T. Sakaguchi, T. Kiba, T. Kubota, A. Ito, K. Sugimori, K. Shirato, M. Morimoto, et al.
Percutaneous Ablation Therapy Guided by Contrast-Enhanced Sonography for Patients with Hepatocellular Carcinoma
Am. J. Roentgenol., January 1, 2003; 180(1): 143 - 149.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Roentgen Ray Society.